title: Overcoming gaps in the management of chronic obstructive pulmonary disease in older patients: new insights.
abstract: Chronic obstructive pulmonary disease (COPD) is a common disorder with a high prevalence among elderly men and women and an increasing mortality rate. Its diagnosis relies on spirometry, with a diagnostic cut-off value of a forced expiratory volume in 1 second (FEV(1))/forced vital capacity ratio of <0.7. This cut-off level has received some criticism because a ratio decline is part of normal advanced aging. Thus, clinicians must be vigilant in applying appropriate diagnostic criteria when managing elderly patients and may choose to use one or more of the alternative diagnostic values that have been created. It is important to remember that COPD is a systemic disorder with several extrapulmonary manifestations. Elderly patients with COPD are at an increased risk of cardiovascular events, osteoporosis, fractures, peripheral muscle wasting, depression and anxiety. Management of these patients requires a multidisciplinary approach and should begin with stratification of disease severity and prognostic information for each patient. Traditionally, FEV(1) has been used as a marker of COPD severity. However, indices such as the Modified Medical Research Council (MMRC) Dyspnoea Scale; the updated body mass, airflow, obstruction, dyspnoea and exercise (BODE) index; and the new age, dyspnoea, obstruction (ADO) index have been found to be better predictors of mortality in elderly patients. In addition to smoking cessation, supplemental oxygen and vaccines, management strategies such as patient education programmes--which have been shown to reduce hospital admissions--should not be overlooked. Pulmonary rehabilitation remains an underutilized treatment modality despite its demonstrated association with improvements in quality of life, reduced dyspnoea and increased exercise capacity. Studies have shown no correlation between age and outcomes in pulmonary rehabilitation, suggesting that age should not be an exclusion criterion. Although bronchodilators and corticosteroids remain the cornerstone of pharmaceutical management of COPD, their efficacy relies on correct medication administration. Inhaler technique should be frequently assessed in the elderly population and the choice of inhaler device needs to be tailored to the patients' needs, situation and preferences. Assessment and management of extrapulmonary co-morbidities of COPD should also be undertaken. Careful attention to the mental health of elderly patients with COPD is also vital, as they have high rates of depression and anxiety. Furthermore, elderly patients with severe COPD receive inadequate palliative care despite the elevated mortality risk associated with this illness. Early discussion about end-of-life care and advanced care planning is recommended.
authors.affiliation: Department of Internal Medicine, Queens University, Kingston, Ontario, Canada.
authors.forename: Jacob
authors.initials: J
authors.lastname: Gelberg
authors.forename: R Andrew
authors.initials: RA
authors.lastname: McIvor
mesh_terms: D000368:Aged; D015897:Comorbidity; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D013727:Terminal Care
references.citation: J Pain Symptom Manage. 2006 Jan;31(1):58-69
references.pmid: 16442483
references.citation: BMJ. 2001 Jul 7;323(7303):49-50
references.pmid: 11464828
references.citation: Eur Respir J. 1996 Mar;9(3):431-5
references.pmid: 8730000
references.citation: Age Ageing. 1988 Jul;17(4):275-8
references.pmid: 3177088
references.citation: Psychosomatics. 2007 Jan-Feb;48(1):16-21
references.pmid: 17209145
references.citation: Lancet. 2009 Aug 29;374(9691):667-8
references.pmid: 19716945
references.citation: Chest. 1985 Jan;87(1):35-8
references.pmid: 3965263
references.citation: J Cardiopulm Rehabil. 2001 Jan-Feb;21(1):10-7
references.pmid: 11271652
references.citation: Chest. 2008 Oct;134(4 Suppl):43S-56S
references.pmid: 18842932
references.citation: Age Ageing. 2008 Sep;37(5):530-5
references.pmid: 18565981
references.citation: Can Fam Physician. 2008 May;54(5):706-11
references.pmid: 18474704
references.citation: Thorax. 1991 Oct;46(10):695-9
references.pmid: 1750015
references.citation: Can Respir J. 2004 Sep;11(6):407-13
references.pmid: 15510248
references.citation: Thorax. 2008 Dec;63(12):1046-51
references.pmid: 18786983
references.citation: Chest. 2005 Apr;127(4):1205-11
references.pmid: 15821196
references.citation: Am J Respir Crit Care Med. 2005 Jul 1;172(1):19-38
references.pmid: 15778487
references.citation: Chest. 2005 Oct;128(4):2068-75
references.pmid: 16236856
references.citation: Chest. 1988 Mar;93(3):580-6
references.pmid: 3342669
references.citation: Can Respir J. 2008 Jan-Feb;15(1):13-9
references.pmid: 18292848
references.citation: Osteoporos Int. 2010 Aug;21(8):1341-9
references.pmid: 19816753
references.citation: Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
references.pmid: 12091180
references.citation: Pharmacoepidemiol Drug Saf. 1996 May;5(3):155-64
references.pmid: 15073832
references.citation: Can Respir J. 2009 Sep-Oct;16(5):e51-3
references.pmid: 19851529
references.citation: Eur Respir J. 1996 Nov;9(11):2346-50
references.pmid: 8947083
references.citation: N Engl J Med. 2007 Feb 22;356(8):775-89
references.pmid: 17314337
references.citation: Chest. 2005 Jun;127(6):2188-96
references.pmid: 15947336
references.citation: Am J Respir Crit Care Med. 2006 Jan 1;173(1):79-83
references.pmid: 16368793
references.citation: Age Ageing. 2004 Nov;33(6):548-55
references.pmid: 15385272
references.citation: Chest. 2002 May;121(5):1434-40
references.pmid: 12006425
references.citation: Chest. 2005 Oct;128(4):2099-107
references.pmid: 16236861
references.citation: Ann Phys Rehabil Med. 2010 Mar;53(2):69-76
references.pmid: 20018583
references.citation: Chest. 2009 Dec;136(6):1456-1465
references.pmid: 19581353
references.citation: N Engl J Med. 2004 Mar 4;350(10):1005-12
references.pmid: 14999112
references.citation: Can Respir J. 2008 Jan-Feb;15 Suppl A:1A-8A
references.pmid: 18292855
references.citation: Eur Respir J. 2006 Dec;28(6):1245-57
references.pmid: 17138679
references.citation: Arch Intern Med. 2003 Mar 10;163(5):585-91
references.pmid: 12622605
references.citation: Am Rev Respir Dis. 1989 Jun;139(6):1435-8
references.pmid: 2658702
references.citation: Eur Respir J. 2008 Sep;32(3):796-803
references.pmid: 17989116
references.citation: Arch Intern Med. 2007 Nov 26;167(21):2345-53
references.pmid: 18039994
references.citation: Can Fam Physician. 2008 May;54(5):737-9
references.pmid: 18474708
references.citation: Am J Respir Crit Care Med. 1999 Dec;160(6):1856-61
references.pmid: 10588597
references.citation: Eur Respir J. 2009 Sep;34(3):588-97
references.pmid: 19460786
references.citation: Eur Respir J Suppl. 2003 Nov;46:52s-63s
references.pmid: 14621107
references.citation: Chest. 2005 Jan;127(1):328-34
references.pmid: 15654000
references.citation: Drugs Aging. 1993 Jul-Aug;3(4):335-48
references.pmid: 8369593
references.citation: Eur Respir J. 1997 Dec;10(12):2801-6
references.pmid: 9493664
references.citation: Age Ageing. 2007 Mar;36(2):213-8
references.pmid: 17267450
references.citation: Am J Respir Crit Care Med. 1998 Aug;158(2):629-34
references.pmid: 9700144
references.citation: Acta Biomed. 2007 Dec;78(3):233-45
references.pmid: 18330086
references.citation: Am J Med. 2003 Jan;114(1):10-4
references.pmid: 12543283
references.citation: Psychosomatics. 2006 Jul-Aug;47(4):312-9
references.pmid: 16844889
references.citation: Can Respir J. 2007 Mar;14(2):87-92
references.pmid: 17372635
references.citation: Eur Respir J. 2002 Nov;20(5):1117-22
references.pmid: 12449163
references.citation: Lancet. 2009 Aug 29;374(9691):704-11
references.pmid: 19716962